BDX : Analysis & Opinions

  1. MedTech Defies Sequestration, M&As Steal the Show - Industry ...

    August 26, 2014
    MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
  2. Four Ways To Spot An Emerging Market

    July 7, 2014
    The term "emerging market" is frustratingly ambiguous. It means a country has at least some market liquidity. But there's ...
  3. MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook

    May 1, 2014
    MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook
  4. Top Trending Tickers On StockTwits For February 4

    February 4, 2014
    Here's a look at the top tickers trending on StockTwits.comS&P 500 ETF: Pre-market data point to opening reboundPrior ...
  5. MedTech Industry Stock Update - Sept 2013 - Industry Outlook

    September 10, 2013
    MedTech Industry Stock Update - Sept 2013 - Industry Outlook
  6. Hologic Struggling To Find A New Path

    August 7, 2013
    Hologic is struggling to become a growth company again, and the new CEO may find his options limited.
  7. ViroPharma and Other Biotech Stocks Recommended by Oppenheimer ...

    June 24, 2013
    Oppenheimer has a new team of analysts focused on biotechnology and specialty pharmaceuticals. And, research from the new ...
  8. Investing For The Global Diabetes Epidemic

    May 31, 2013
    Sadly, diabetes is quickly becoming a global epidemic. Within these grim statistics, investors can find opportunities with ...
  9. Recent Financials May Not Be Entirely Fair To Hologic

    May 8, 2013
    Macro pressures are outweighing solid internal progress at Hologic.
  10. In A Growth-Starved Sector, Becton Dickinson Rules

    May 3, 2013
    Becton Dickinson is a great business, but investors seem to be too willing to overpay for today's relatively stronger growth. ...
  11. CONMED Beats 4Q Estimates - Analyst Blog

    February 15, 2013
    CONMED Corporation (CNMD), a medical technologies and surgical devices company, reported fourth-quarter 2012 adjusted earnings ...
  12. Time For Hologic To Translate Technology Into Results

    November 14, 2012
    Hologic has to take market-leading technology and translate it into strong cash flow.
  13. Corning Closes BD Labware Unit Buy - Analyst Blog

    November 2, 2012
    Corning Inc. (GLW) recently completed its acquisition of the majority portion of the Discovery Labware unit from Becton, ...
  14. Slew of Product Recalls at Covidien - Analyst Blog

    August 24, 2012
    Recently, health care products major Covidien plc. (COV) has been hit by a number of product recalls, the most significant ...
  15. Bio-Reference Labs Taking Advantage Of Esoteric Opportunities

    June 22, 2012
    The decision of whether to buy Bio-Reference really comes down to an investor's confidence in the growth prospects for the ...
  16. Becton Dickinson Safe And Steady

    June 13, 2012
    Becton stands out for having one of the clearest growth strategies in its field as well as a solid track record of delivering ...
  17. Covidien Promotes Zogenix's Product - Analyst Blog

    June 8, 2012
    The pharmaceutical unit of Covidien plc (COV) and Zogenix Inc. (ZGNX) have recently agreed to co-endorse a prescription medicine ...
  18. CareFusion: Is It Still Cheap?

    May 3, 2012
    The biggest concern investors have with CareFusion is its low return on invested capital. Until it creates higher free cash ...
  19. Modest But Predictable Growth At C.R. Bard

    April 26, 2012
    C.R. Bard is posting modest operational growth but there is ample downside protection.
  20. Becton Dickinson Still A Fine Specimen

    February 10, 2012
    Becton Dickinson hasn't been growing very rapidly lately, but the company has experienced sustained growth over the last ...
  21. Will Qiagen's Restructuring Address The Real Problems?

    November 30, 2011
    Will Qiagen's Restructuring Address The Real Problems?
  22. Covidien Delivers Once Again

    November 21, 2011
    Covidien is overlooked and undervalued.
  23. Meridian Biosciences – Stealth Income Play

    November 16, 2011
    Meridian offers an impressive dividend, but a high valuation as well.
  24. Is Hologic A Coiled Spring?

    November 11, 2011
    Hologic looks cheap on even modest growth recovery expectations.
  25. If CareFusion Can Execute, This Is A Major Bargain

    November 9, 2011
    CareFusion has to make some improvements, but it could really reward investors.
  26. BD Healthy, But No Great Bargain

    August 9, 2011
    BD is not the cheapest health care name, but it comes with a lot of quality.
  27. Covidien's Image Starting To Change

    August 3, 2011
    Find out why Covidien is much better than many investors assume.
  28. Against All Odds, Some Stocks Near All-Time Highs

    June 23, 2011
    Despite the recent weakness, some stocks remain near record highs.
  29. Hologic Holding The Line

    May 4, 2011
    Hologic lacks exciting growth, but the technology is in place for better growth in the future.
  30. Danaher Hopes To Revive Beckman Coulter

    February 9, 2011
    Learn more about Danaher's expensive, albeit strategic, bid for a leading diagnostics franchise.
  31. Abbott Labs Showing Meaningful Growth

    October 21, 2010
    Abbott might just be the best healthcare stock today.
  32. Money To Be Made In Medical Devices

    September 22, 2010
    New advances in medical devices will not only help patients live better lives, but they'll power portfolios as well.
  33. Investing For The Diabetes Epidemic

    July 30, 2010
    Sadly, diabetes is quickly becoming a global epidemic. Nearly 300 million people suffer from the disease worldwide.
  34. Great Dividend Payers In Medical Technology

    May 21, 2010
    Dividend-paying stocks are not common in medical technology, but these four proven winners deliver the goods.
  35. Becton Dickinson More Interesting Than You Think

    May 3, 2010
    Becton Dickinson is often dismissed as "boring" but a diversified cash-generating business with real growth shouldn't be. ...
  36. Covidien Happy With Tyco Split

    March 3, 2010
    Projections for double-digit profit increases at Covidien would easily take care of any valuation concerns at current levels. ...
  37. Funds With Low Fees And Commissions

    September 3, 2009
    Fees lead to diminishing returns, so it's best to invest in funds with little or no fees.
  38. Baxter A Healthy Healthcare Holding

    April 22, 2009
    Baxter's recent results demonstrate why it continues as a leader in its industry and should be considered a core healthcare ...
Trading Center